Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News New therapeutic avenues in bone repair The latest research shows that PEPITEM could be used as a novel and early clinical intervention to reverse the impact of age-related musculoskeletal diseases.
News Midland Pharmaceuticals – a new company to develop therapeutics for spinal cord injury and stroke
20 May 2022 Birmingham research brings hope for spinal cord injury treatment Birmingham scientists have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
14 January 2022 New ethnicity report highlights variation in health outcomes in rheumatology practice Dr Kanta Kumar together with rheumatology teams across the UK has played a key role in the Healthcare Quality Improvement Partnership report.
05 January 2022 Institute of Inflammation and Ageing Award Success The University of Birmingham's Institute of Inflammation and Ageing has been awarded four major grants.